Novel osteoporosis drug romosozumab approved in Japan
8 days ago - By Healio
The Japanese Ministry of Health, Labor and Welfare granted a marketing authorization this week for the monoclonal antibody romosozumab for the treatment of osteoporosis in patients at high risk for fracture, Amgen and UCB Pharma announced in a press release.
"The approval of Evinity in Japan is a significant milestone that reinforces our commitment to bringing effective treatments to the millions of patients who suffer from osteoporosis," David M. Reese, MD, executive vice president of research and development at Amgen, said in the release. "A patient with a prior osteoporotic fracture is
Read more ...